Aspergillus spondylodiscitis in a patient with liver cirrhosis and diabetes mellitus
Abstract
Aspergillus osteomyelitis is a rare manifestation of invasive aspergillosis which accounts for 1.8% to 5.6% of all invasive aspergillosis forms. As other forms of invasive aspergillosis, it predominantly occurs in immunosupressed patients with well established risk factors, but there are increasing reports of invasive aspergillosis cases in patients without traditional risk factors such as patients with chronic obstructive pulmonary disease on inhalatory corticosteroid therapy or patients with liver cirrhosis. We present a case of Aspergillus spondylodiscitis in a patient without other risk factors for invasive aspergillosis than liver cirrhosis and diabetes mellitus successfully treated with a 4-month course of voriconasole.
Downloads
References
Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 1990; 12: 1147–201.
Horn D, Sae-Tia S, Neofytos D. Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry. Diagn Microbiol Infect Dis 2009; 63: 384–7.
Mouas H, Lutsar I, Dupont B, Fain O, Herbrecht R, Lescure F-X et al. Voriconasole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin Infect Dis 2005; 40: 1141–7.
Vinas FC, King PK, Diaz FG. Spinal Aspergillus osteomyelitis. Clin Infect Dis 1999; 28: 1223–9.
Patterson TF. Aspergillus species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglass and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone; 2010. p. 3241–55.
Nicolle A, de la Blanchardière A, Bonhomme J, Hamon M, Leclercq R, Hitier M. Aspergillus vertebral osteomyelitis in immunocompetent subjects: case report and review of the literature. Infection 2013; 41: 833–40.
Meersseman W, Lagrou K, Maertens J, Van Wijngaerden. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007; 45: 205–16.
Falcone M, Massetti AP, Russo A, Vullo V, Venditti M. Invasive aspergillosis in patients with liver disease. Med Mycol 2011; 49: 406–13.
Prodanovic H, Cracco C, Massard J, Barrault C, Thabut D, Duguet A, et al. Invasive pulmonary aspergillosis with decompensated cirrhosis: case series. BMC Gastroenterol 2007; 7: 2.
Russo A, Falcone M, Vena A, Venditti C, Mancini C, Morelli A, et al. Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience. J Chemother 2011; 23: 290–4.
Fiuza C, Salcedo M, Clemente G, Tellado JM. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000; 182: 526–33.
Lombardo L, Capaldi A, Poccardi G, Vineis P. Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis. Int J Clin Lab Res 1995; 25: 153–6.
Rudagi BM, Rajshekhar H, Kalburge J, Joshi M, Munde A, Saluja H. Management of maxillary aspergillosis in a patient with diabetes mellitus followed by prosthetic rehabilitation. J Maxillofac Oral Surg 2010; 9: 297–301.
Studemeister A, Stevens DA. Aspergillus osteomyelitis in immunocompetent hosts: role of triazole antifungal therapy. Clin Infect Dis 2011; 52: e1–6.
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative group and the National Institute of Allergy and Infectious Diseases Mycose Study Group (EORCT/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–21.
Denes F, Boumediene A, Durox H, Oksman A, Saint-Marcoux F, Darde ML, et al. Voriconazole concentrations in synovial fluid and bone tissues. J Antimicrob Chemother 2007; 59: 818–9.
Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis. Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008, 46: 327–60.
Rex JH, Stevens DA. Systemic antifungal agents. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglass and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone; 2010. p. 549–63.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
